Hybrid Quantum Cycle Generative Adversarial Network for Small Molecule Generation

The drug design process currently requires considerable time and resources to develop each new compound that enters the market. This work develops an application of hybrid quantum generative models based on the integration of parameterized quantum circuits into known molecular generative adversarial...

Full description

Saved in:
Bibliographic Details
Main Authors: Matvei Anoshin, Asel Sagingalieva, Christopher Mansell, Dmitry Zhiganov, Vishal Shete, Markus Pflitsch, Alexey Melnikov
Format: Article
Language:English
Published: IEEE 2024-01-01
Series:IEEE Transactions on Quantum Engineering
Subjects:
Online Access:https://ieeexplore.ieee.org/document/10556803/
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832586885753470976
author Matvei Anoshin
Asel Sagingalieva
Christopher Mansell
Dmitry Zhiganov
Vishal Shete
Markus Pflitsch
Alexey Melnikov
author_facet Matvei Anoshin
Asel Sagingalieva
Christopher Mansell
Dmitry Zhiganov
Vishal Shete
Markus Pflitsch
Alexey Melnikov
author_sort Matvei Anoshin
collection DOAJ
description The drug design process currently requires considerable time and resources to develop each new compound that enters the market. This work develops an application of hybrid quantum generative models based on the integration of parameterized quantum circuits into known molecular generative adversarial networks and proposes quantum cycle architectures that improve model performance and stability during training. Through extensive experimentation on benchmark drug design datasets, quantum machine 9 (QM9) and PubChemQC 9 (PC9), the introduced models are shown to outperform the previously achieved scores. Most prominently, the new scores indicate an increase of up to 30% in the quantitative estimation of druglikeness. The new hybrid quantum machine learning algorithms, as well as the achieved scores of pharmacokinetic properties, contribute to the development of fast and accurate drug discovery processes.
format Article
id doaj-art-befb5560bf3b49f8b5b0fcb555027d50
institution Kabale University
issn 2689-1808
language English
publishDate 2024-01-01
publisher IEEE
record_format Article
series IEEE Transactions on Quantum Engineering
spelling doaj-art-befb5560bf3b49f8b5b0fcb555027d502025-01-25T00:03:35ZengIEEEIEEE Transactions on Quantum Engineering2689-18082024-01-01511410.1109/TQE.2024.341426410556803Hybrid Quantum Cycle Generative Adversarial Network for Small Molecule GenerationMatvei Anoshin0https://orcid.org/0009-0008-5538-4490Asel Sagingalieva1https://orcid.org/0009-0009-3931-3702Christopher Mansell2https://orcid.org/0009-0006-1745-8458Dmitry Zhiganov3https://orcid.org/0009-0004-1376-8366Vishal Shete4https://orcid.org/0009-0003-1556-794XMarkus Pflitsch5Alexey Melnikov6https://orcid.org/0000-0002-5033-4063Terra Quantum AG, St. Gallen, SwitzerlandTerra Quantum AG, St. Gallen, SwitzerlandTerra Quantum AG, St. Gallen, SwitzerlandTerra Quantum AG, St. Gallen, SwitzerlandTerra Quantum AG, St. Gallen, SwitzerlandTerra Quantum AG, St. Gallen, SwitzerlandTerra Quantum AG, St. Gallen, SwitzerlandThe drug design process currently requires considerable time and resources to develop each new compound that enters the market. This work develops an application of hybrid quantum generative models based on the integration of parameterized quantum circuits into known molecular generative adversarial networks and proposes quantum cycle architectures that improve model performance and stability during training. Through extensive experimentation on benchmark drug design datasets, quantum machine 9 (QM9) and PubChemQC 9 (PC9), the introduced models are shown to outperform the previously achieved scores. Most prominently, the new scores indicate an increase of up to 30% in the quantitative estimation of druglikeness. The new hybrid quantum machine learning algorithms, as well as the achieved scores of pharmacokinetic properties, contribute to the development of fast and accurate drug discovery processes.https://ieeexplore.ieee.org/document/10556803/Drug designhybrid quantum neural network (HQNN)quantum generative adversarial network (GAN)quantum machine learning (QML)variational quantum circuit (VQC)
spellingShingle Matvei Anoshin
Asel Sagingalieva
Christopher Mansell
Dmitry Zhiganov
Vishal Shete
Markus Pflitsch
Alexey Melnikov
Hybrid Quantum Cycle Generative Adversarial Network for Small Molecule Generation
IEEE Transactions on Quantum Engineering
Drug design
hybrid quantum neural network (HQNN)
quantum generative adversarial network (GAN)
quantum machine learning (QML)
variational quantum circuit (VQC)
title Hybrid Quantum Cycle Generative Adversarial Network for Small Molecule Generation
title_full Hybrid Quantum Cycle Generative Adversarial Network for Small Molecule Generation
title_fullStr Hybrid Quantum Cycle Generative Adversarial Network for Small Molecule Generation
title_full_unstemmed Hybrid Quantum Cycle Generative Adversarial Network for Small Molecule Generation
title_short Hybrid Quantum Cycle Generative Adversarial Network for Small Molecule Generation
title_sort hybrid quantum cycle generative adversarial network for small molecule generation
topic Drug design
hybrid quantum neural network (HQNN)
quantum generative adversarial network (GAN)
quantum machine learning (QML)
variational quantum circuit (VQC)
url https://ieeexplore.ieee.org/document/10556803/
work_keys_str_mv AT matveianoshin hybridquantumcyclegenerativeadversarialnetworkforsmallmoleculegeneration
AT aselsagingalieva hybridquantumcyclegenerativeadversarialnetworkforsmallmoleculegeneration
AT christophermansell hybridquantumcyclegenerativeadversarialnetworkforsmallmoleculegeneration
AT dmitryzhiganov hybridquantumcyclegenerativeadversarialnetworkforsmallmoleculegeneration
AT vishalshete hybridquantumcyclegenerativeadversarialnetworkforsmallmoleculegeneration
AT markuspflitsch hybridquantumcyclegenerativeadversarialnetworkforsmallmoleculegeneration
AT alexeymelnikov hybridquantumcyclegenerativeadversarialnetworkforsmallmoleculegeneration